AptarGroup Inc (ATR)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$120.00

Buy

$134.35

arrow-down$-0.74 (-0.58%)

Prices updated at 02 Apr 2026, 23:27 EDT
| Prices minimum 15 mins delay
|
Prices in USD

AptarGroup, Inc. is a solution provider of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets.

Income statement

20242025
3,583m3,777m
1,356m1,405m
509m511m
14.2213.53
375m393m
777m831m
Sales, General and administrative582m606m
Interest expenses44m53m
Provision for income taxes96m99m
Operating expenses846m894m
Income before taxes470m491m
Net income available to common shareholders375m393m
5.655.97
Net interest income-32m-41m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)5.535.89
Free cash flow per share5.59934.549
Book value/share38.180643.1333
Debt equity ratio0.2984690.445026

Balance sheet

20242025
Current assets1,478m1,894m
Current liabilities1,068m1,166m
Total capital3,160m3,808m
Total debt1,076m1,531m
Total equity2,472m2,668m
Total non current liabilities--
Loans688m1,139m
Total assets4,432m5,253m
Total liabilities--
Cash and cash equivalents224m402m
Common stock67m64m

Cash flow

20242025
Cash at beginning of period224m224m
Cash dividends paid-114m-121m
349m295m
Investments (gains) losses-397m-331m
224m405m
Net income--
643m570m
-294m-275m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.